BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35354106)

  • 1. Functional analysis of ATM variants in a high risk cohort provides insight into missing heritability.
    Baughan SL; Darwiche F; Tainsky MA
    Cancer Genet; 2022 Jun; 264-265():40-49. PubMed ID: 35354106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.
    Petrackova A; Savara J; Turcsanyi P; Gajdos P; Papajik T; Kriegova E
    Br J Haematol; 2022 Nov; 199(3):371-381. PubMed ID: 36029002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.
    Marabelli M; Cheng SC; Parmigiani G
    Genet Epidemiol; 2016 Jul; 40(5):425-31. PubMed ID: 27112364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients.
    DeLeonardis K; Sedgwick K; Voznesensky O; Matloff E; Hofstatter E; Balk S; Tung N
    Breast J; 2017 Jul; 23(4):461-464. PubMed ID: 28139868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant negative ATM mutations in breast cancer families.
    Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
    J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
    Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL
    J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of Breast Radiotherapy Among Carriers of
    Modlin LA; Flynn J; Zhang Z; Cahlon O; Mueller B; Khan AJ; Gillespie EF; McCormick B; Stadler ZK; Robson ME; Powell SN; Braunstein LZ
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
    Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
    Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of New
    Parenti S; Rabacchi C; Marino M; Tenedini E; Artuso L; Castellano S; Carretta C; Mallia S; Cortesi L; Toss A; Barbieri E; Manfredini R; Luppi M; Trenti T; Tagliafico E
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33494414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.
    West AH; Blazer KR; Stoll J; Jones M; Weipert CM; Nielsen SM; Kupfer SS; Weitzel JN; Olopade OI
    Fam Cancer; 2018 Oct; 17(4):495-505. PubMed ID: 29445900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
    Renwick A; Thompson D; Seal S; Kelly P; Chagtai T; Ahmed M; North B; Jayatilake H; Barfoot R; Spanova K; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
    Nat Genet; 2006 Aug; 38(8):873-5. PubMed ID: 16832357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
    Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
    Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering variable neoplasms between ATM protein-truncating and common missense variants using 394 694 UK Biobank exomes.
    Jiang X; O'Neill A; Smith KR; Lai Z; Carss K; Wang Q; Petrovski S
    Genes Chromosomes Cancer; 2022 Sep; 61(9):523-529. PubMed ID: 35394676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.
    Mitui M; Nahas SA; Du LT; Yang Z; Lai CH; Nakamura K; Arroyo S; Scott S; Purayidom A; Concannon P; Lavin M; Gatti RA
    Hum Mutat; 2009 Jan; 30(1):12-21. PubMed ID: 18634022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
    Bandeira G; Rocha K; Lazar M; Ezquina S; Yamamoto G; Varela M; Takahashi V; Aguena M; Gollop T; Zatz M; Passos-Bueno MR; Krepischi A; Okamoto OK
    Breast Cancer; 2021 Mar; 28(2):346-354. PubMed ID: 32986223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM, radiation, and the risk of second primary breast cancer.
    Bernstein JL; ; Concannon P
    Int J Radiat Biol; 2017 Oct; 93(10):1121-1127. PubMed ID: 28627265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM.
    Renault AL; Dowty JG; Steen JA; Li S; Winship IM; Giles GG; Hopper JL; Southey MC; Nguyen-Dumont T
    Breast Cancer Res; 2022 Apr; 24(1):24. PubMed ID: 35365198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional classification of ATM variants in ataxia-telangiectasia patients.
    Fiévet A; Bellanger D; Rieunier G; Dubois d'Enghien C; Sophie J; Calvas P; Carriere JP; Anheim M; Castrioto A; Flabeau O; Degos B; Ewenczyk C; Mahlaoui N; Touzot F; Suarez F; Hully M; Roubertie A; Aladjidi N; Tison F; Antoine-Poirel H; Dahan K; Doummar D; Nougues MC; Ioos C; Rougeot C; Masurel A; Bourjault C; Ginglinger E; Prieur F; Siri A; Bordigoni P; Nguyen K; Philippe N; Bellesme C; Demeocq F; Altuzarra C; Mathieu-Dramard M; Couderc F; Dörk T; Auger N; Parfait B; Abidallah K; Moncoutier V; Collet A; Stoppa-Lyonnet D; Stern MH
    Hum Mutat; 2019 Oct; 40(10):1713-1730. PubMed ID: 31050087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.